Nigerians are now paying three times more for antibiotics formerly produced by the British pharmaceutical giant, GlaxoSmithKline (GSK), one year after its exit.
Prices of GSK’s signature products, Augmentin 228mg and 475mg, have skyrocketed by 307 percent and 328 percent respectively between Au
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
